Axios Access Tools
Patient Financial Evaluation Tool
Driving sustainable access and better health outcomes by helping patients complete their treatment.
Overview
Powering Sustainable Patient Access
The Patient Financial Evaluation Tool (PFET) is Axios’ validated, means-based assessment tool for determining the level of financial support a patient needs to complete their full course of treatment. Purpose-built for emerging markets and low- and middle-income countries, PFET helps make patient access programs more sustainable by reducing early treatment discontinuation and avoiding the “start-stop” dynamic that can compromise health outcomes.
Value
What Does PFET Solve?
PFET is an essential component of an effective treatment access program because it supports sustainability for both patients and pharmaceutical companies.
Greater
Accuracy
Delivers a more accurate assessment of patient affordability by considering factors beyond household income.
Broader Patient
Reach
Expands the viable patient pool by reaching patients across the affordability spectrum.
Improved Treatment Adherence
Supports longer treatment duration compared to fixed-scheme access programs.
Simple for Physicians and Patients
Straightforward assessment with dedicated support, giving patients peace of mind while allowing physicians to focus on prescribing the right treatment.
By The Numbers
Widely Used and Trusted Around the World
45k
patients
35+
Countries
2x
longer treatment duration
More than 28 years of experience have shaped how we understand and address patient financial need. That experience comes together in PFET to deliver more equitable and sustainable access.
Publications
Why PFET
The Only Validated Means-Based Assessment Tool
PFET has been rigorously tested across statistical and operational dimensions, demonstrating accuracy, consistency, and real-world applicability.
Independent external assessments confirmed PFET as a statistically robust and accurate measure of a patient’s ability to pay (see above).
axios in action
Featured Case Study
From One Country to 20: Scaling Patient Access Globally
Axios partnered with a multinational pharmaceutical company to develop a scalable patient assistance model that adapted to local financial realities and expanded across 20 countries, helping more than 7,600 patients access and complete essential treatments.
